CAPhO 2026 Prostate Cancer Pharmacotherapy Review with Focus on Treatment Intensification

Concurrent Session

Treatment of prostate cancer has always required careful balancing of treatment benefits and harms. We will discuss risk stratification from landmark clinical trials to identify patients most likely to benefit from pharmacotherapy. From newly diagnosed local disease to metastatic cases, current therapy options will be reviewed including what is meant by treatment intensification and when it should be employed.

*This presentation was developed by Michelle Deschamps, Senior Oncology Pharmacist at SCA. Lana kindly stepped in on short notice to present on Michelle’s behalf due to unforeseen circumstances.